Top Abstract Purchase Related
Home
>
Node
>
Subnode

Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse

Baltz, M.L.; Dyck, R.F.; Pepys, M.B.

Clinical and Experimental Immunology 59(1): 235-242

1985

ISSN/ISBN: 0009-9104
PMID: 3882285
Document Number: 261294
The production of mouse serum amyloid P component (SAP), a major acute phase protein of liver origin, was studied immunocytochemically using the peroxidase staining technique. SAP was not detectable in the cytoplasm of hepatocytes from normal, unstimulated mice, nor was it observed before 24 h after an acute phase stimulus. 125I-labelled mouse SAP was cleared from the plasma in vivo with a half-life of 7.0-8.25 h in all animals studied including: normal mice of different strains with different genetically determined plasma SAP concentrations; mice undergoing acute phase responses with greatly elevated plasma SAP levels and mice with casein-induced amyloidosis. The circulating level of SAP is thus independent of its rate of clearance and catabolism and is determined by the rate of synthesis and/or secretion of SAP.

Document emailed within 1 workday
Secure & encrypted payments

Baltz, M.L.; Gomer, K.; Davies, A.J.; Evans, D.J.; Klaus, G.G.; Pepys, M.B. 1980: Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains Clinical and Experimental Immunology 39(2): 355-360
Bottomley, K.M.; Rising, T.J.; Steward, A. 1988: The serum amyloid P response in the mouse air pouch Journal of Pharmacy and Pharmacology 40(3): 227-228
Johnson, H.L. 1971: Nonmast-cell histamine kinetics. IV. Interrelationships between synthesis, binding and catabolism of 3 H-histamine in vivo Journal of Pharmacology and Experimental Therapeutics 177(3): 579-590
Voss, A.; Nielsen, E.Holm.; Svehag, S.Erik.; Junker, P. 2008: Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies Journal of Rheumatology 35(4): 625-630
Sipe, J.D.; Ignaczak, T.F.; Pollock, P.S.; Glenner, G.G. 1976: Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay Journal of Immunology 116(4): 1151-1156
Shimizu, H.; Mitomo, K.; Yamamoto, K. 1992: Regulation of mouse serum amyloid A3 gene expression during acute phase reaction Folia Histochemica et Cytobiologica 30(4): 141-142
Kedar, I.; Sohar, E.; Ravid, M. 1982: Degradation of amyloid by a serum component and inhibition of degradation Journal of Laboratory and Clinical Medicine 99(5): 693-700
Mizuno, Y.; Suzuki, K.; Sone, N. 1990: Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in mouse brain in vitro and in vivo Advances in Neurology 53: 197-200
Roth, P.; Bartocci, A.; Stanley, E.R. 1997: Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo Journal of Immunology 158(8): 3874-3880
Rodin, D.V.; Kolesnikov, V.A.; Srdiuk, O.V.; Zelenina, I.A.; Zelenin, A.V.; Deev, S.M. 2000: Synthesis of chimeric IgE in vivo after ballistic transfection of immunoglobulin genes in various mouse tissues Molekuliarnaia Biologiia 34(1): 18-23
Poser, R.G.; Sirotnak, F.M.; Chello, P.L. 1981: Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo Cancer Research 41(11 Part 1): 4441-4446
Weinstein, J.A.; Taylor, J.M. 1987: Interleukin-1 and the acute-phase response: induction of mouse liver serum amyloid a mRNA by murine recombinant interleukin-1 Journal of Trauma 27(11): 1227-1232
Caspi, D.; Baltz, M.L.; Feinstein, A.; Munn, E.A.; Pepys, M.B. 1984: 'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils Clinical and Experimental Immunology 57(3): 647-656
Baltz, M.L.; Rowe, I.F.; Caspi, D.; Turnell, W.G.; Pepys, M.B. 1986: Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? Clinical and Experimental Immunology 66(3): 701-708
Goel, M.C. 1984: Studies on an immunoglobulin-like component in chicken serum Indian Journal of Experimental Biology 22(7): 353-356
Gershbein, L.L.; Feder, J. 1970: In vivo gall bladder contractility by male mouse blood serum Research Communications in Chemical Pathology and Pharmacology 1(6): 757-760
Devi, P.U.; Kamath, R.; Rao, B.S. 2000: Radiosensitization of a mouse melanoma by withaferin A: in vivo studies Indian Journal of Experimental Biology 38(5): 432-437
Tsunoda, Y.; Chang, M.C. 1977: Further studies of antisera on the fertilization of mouse, rat, and hamster eggs in vivo and in vitro International Journal of Fertility 22(3): 129-139
Lovett, M.; Goldgaber, D.; Ashley, P.; Cox, D.R.; Gajdusek, D.C.; Epstein, C.J. 1987: The mouse homolog of the human amyloid beta protein (AD-AP) gene is located on the distal end of mouse chromosome 16: further extension of the homology between human chromosome 21 and mouse chromosome 16 Biochemical and Biophysical Research Communications 144(2): 1069-1075
Girault, J.P.; Lafont, R.; Kerb, U. 1988: Ecdysone catabolism in the white mouse Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(5): 716-720